. A heat map exhibiting broad suppression of cholesterol synthesis pathway in the hypothalamus of STZ-diabetic mice based on microarray data, related to Figure 1 . Each column represented one Affymetrix chip hybridized using the cRNA synthesized from one mouse hypothalamus. Blood glucose levels at the time of sacrifice are indicated above the columns. "Cholesterol biosynthesis" gene sets were significantly reduced in the STZ group compared to the others (nominal P-value < 0.001, FDR Q-value = 0.033, FWER P-value = 0.023, as analyzed by GSEA v2.0 software). Colors represent gene expression values in individual subject expression changes relative to the mean, with red representing higher and blue representing lower expression.
. A heat map exhibiting broad suppression of cholesterol synthesis pathway in the hypothalamus of STZ-diabetic mice based on microarray data, related to Figure 1 . Each column represented one Affymetrix chip hybridized using the cRNA synthesized from one mouse hypothalamus. Blood glucose levels at the time of sacrifice are indicated above the columns. "Cholesterol biosynthesis" gene sets were significantly reduced in the STZ group compared to the others (nominal P-value < 0.001, FDR Q-value = 0.033, FWER P-value = 0.023, as analyzed by GSEA v2.0 software). Colors represent gene expression values in individual subject expression changes relative to the mean, with red representing higher and blue representing lower expression. Comparison of the major cholesterologenic enzymes and SREBP-2 gene expression in hypothalami from chow-diet-fed (n = 6) and high-fat-fed (n = 6) C57Bl/6 mice was performed by qPCR. (B) Gene expression in hypothalamus of control (n = 6) and ob/ob (n = 5) mice was assessed. (C) Cholesterol synthetic gene regulation by 24 hours fasting was investigated in the brain-specific insulin receptor knockout (NIRKO) and control mouse hypothalami (n = 7 in each group). Average expression values in fed control hypothalami are indicated as 1.0. *, P < 0.05; **, P < 0.01; ***, P < 0.001 between fed and fasted states in each genotype. §, P < 0.05 between control and NIRKO hypothalami in a correspondent feeding status. ANOVA was employed to compare the 2 (genotypes) x 2 (feeding status) groups. Glia cells were incubated with medium containing DMSO (control), a PI 3-kinase inhibitor LY294002 (LY), a MEK inhibitor U0126 (U), and/or an mTORC1 inhibitor rapamycin (Rapa) prior to insulin stimulation. #, P < 0.05 (comparison with DMSO/insulin treated group). *, P < 0.05; **, P < 0.01 by ANOVA. (B) Rapamycin treatment (0.5 µM) was followed by incubation with a GSK3 inhibitor SB216763 (SB) and/or insulin. *, P < 0.05; **, P < 0.01 by ANOVA (comparison with DMSO/DMSO treated groups (white bars)). Food intake of the male C57Bl/6 mice with ihp injection of Lenti-shSREBP2 (n = 18) and control Lenti-NS (n = 19). Food was measured twice a day from day 15 after the injection for consecutive 12 days. (C) Plasma glucagon concentrations in mice with ihp injection of Lenti-NS (n = 10) and Lenti-shSREBP2 (n = 10) after 24 hours of fasting. (D) Insulin tolerance tests and (E) glucose tolerance tests of the mice with ihp injection of Lenti-shSREBP2 (n = 10) and control Lenti-NS (n = 10). (F) Activity and oxygen consumption levels of the mice with ihp injection of Lenti-shSREBP2 (n = 8) and control Lenti-NS (n = 8) during 72 hours in metabolic chambers. *, P < 0.05 by t-test.
Supplemental Experimental Procedures

Food
Mice were maintained on a 12-h light/12-h dark cycle and fed a standard mouse chow diet (LabDiet Mouse Diet 9 F, PMI Nutrition International, Brentwood, MO). As a diet-induced obesity (DIO) model, C57Bl/6 mice were fed with 60% kcal fat diet (D12492, Research Diet Inc., New Brunswick, NJ) for 6 months.
RNA Extraction and Gene Expression Analysis by quantitative PCR
RNA from murine brain tissue, primary cultured cells, and human cerebral cortices was isolated using an RNeasy kit (Qiagen). As a template, 1 µg (for tissue) or 0.2 µg (for glia and neurons) of total RNA was reverse-transcribed in 50 µl using a High Capacity cDNA Reverse Transcription Kit (Applied Biosystems) according to the manufacturer's instructions. Three microliters of diluted (1/4) reverse transcription reaction was amplified with specific primers (300 nM each) in a 25 µl PCR with a SYBR Green PCR Master Mix (Applied Biosystems).
Analysis of gene expression was done in the ABI PRISM 7000 sequence detector with an initial denaturation at 95 ºC for 10 minutes followed by 40 PCR cycles, each cycle consisting of 95 ºC for 15 seconds and 60 ºC for 1 minute, and SYBR Green fluorescence emissions Suzuki et al.
were monitored after each cycle. For each gene, mRNA expression was calculated relative to Tbp (mouse) or ribosomal 18S (human) expression as an internal control.
Immunoblotting
Nuclear and cytoplasmic extracts were prepared using total hypothalamus (about 30 mg) per the manufacturer's directions (NE-PER kit, Pierce). Brain tissue extracts were homogenized in Cell Disruption Buffer (PARIS kit, Ambion). Protein concentrations were measured using a BCA assay (Pierce). Immunoblotting was performed with antibodies against HMGCR (Millipore), FDPS (Abcam), SQLE (ProteinTech, Chicago, IL), actin (Santa Cruz), lamin (Cell Signaling Technology), SREBP-1, or SREBP-2 (gifts from Drs.
Jay Horton and Guosheng Liang).
Synaptosome Isolation
About 100 mg of frontal cortex tissue from the 10-week-old C57Bl/6 male mice 18 days after STZ injection or human cerebral cortex tissue was homogenized in 1 mL of 0.32 M sucrose buffered with HEPES (10 mM, pH 7.4) at 4 ºC by using a glass-Teflon Dounce homogenizer, then centrifuged 1,500 x g for 10 min at 4 ºC. The supernatant (A) was collected, and the fluffy, white layer above the pellet was discarded. The pellet obtained after centrifugation was resuspended in 1 mL of 0.32 M sucrose buffer and centrifuged again. The supernatants obtained (B) was combined with supernatant (A) and centrifuged again at 9,000 x g for 20 min, 4 ºC. The pellet (crude synaptosomal fraction containing myelin, synaptosomes and mitochondria) was resuspended in 500 µL of 0.32 M sucrose buffer, and every 250 µL of the suspension was layered over 1 mL of 0.8 M sucrose buffer. After centrifugation at 9,000 x g for 25 min, pellets were resolved into three fractions: a thick white band at the 0.32-0.8 M sucrose interface (mainly myelin); pellets dispersed in the 0.8 M sucrose solution (mainly synaptosomes); and a pellet (mainly mitochondria). The synaptosome-rich fraction in the 0.8 M sucrose buffer was diluted with 0.1 M sucrose to obtain a final 0.32 M sucrose buffer, and centrifuged under the same conditions as the previous gradient. The pellets of synaptosomes was washed by ice-cold PBS and resuspended in 500 µL of 5 µM Tris-HCL buffer (pH 7.4), then placed on ice for 30 min. The pellet containing synaptosomal membranes was lysed with buffer containing 1% Triton-X.
Cholesterol was measured by an enzymatic assay (Wako Chemicals). Protein concentrations were measured by BCA assay.
Primary Culture Glia and Cortical Neurons for Insulin and Glucose Stimulation
For primary culture glia cells, the cerebral cortex was dissected from 0-1 day old C57Bl/6 mice under aseptic conditions. Large blood vessels were carefully removed under the microscope. The tissue was coarsely minced by forceps in ice-cold L15 medium and rinsed in ice-cold PBS for 5 times. The cortex was digested in 0.25% trypsin and 10 µg/ml DNase (Roche) at 37 ºC for 15 minutes. After adding an equal volume of horse serum, the tissue was centrifuged at 600 x g for 5 minutes. The pellet was suspended in Minimum Essential Medium (MEM) containing 10% horse serum and filtered through a 40 µm nylon cell strainer (BD Falcon). The cell suspension was plated on poly-L-lysine (PLL)-coated 12 well plates in MEM with 10% horse serum. Medium was replaced every 4 days after the initial plating.
Primary culture cortical neurons were prepared from E16 embryonic C57Bl/6 mouse brains. Neurons were plated at a density of 2 x 10 5 cells/cm 2 on PLL-coated plates in Dulbecco's modified Eagle medium (DMEM) and Ham's F-12 medium (1:1) supplemented with 5% fetal bovine serum and 5% horse serum. Cytosine arabinoside (10 µM) was added to the culture medium 2 days after plating. The medium was replenished by half every 4 days.
Immunofluorescent Staining
Hippocampal neurons were fixed with 4% PFA for 15 min, and permeabilized with 0.25% Triton X-100 in PBS for 5 min. After cells were blocked with PBS containing 10%
BSA for 30 min, they were incubated with the first antibody (anti-PSD95, Abcam, 1:500;
anti-VAMP2, Abcam, 1:1000; anti-MAP2, Millipore, 1:200) in PBS containing 3% BSA overnight at 4ºC, washed with PBS, and incubated with the second antibody in PBS containing 3% BSA for 1 hour. After the samples were washed with PBS, they were embedded in fluorescence mounting medium (DAKO). The images were obtained by confocal microscopy (Zeiss LSM-410), and quantified by ImageJ software (NIH).
Microarray Analysis
RNA was isolated from 9-week-old male control C57Bl/6 (n = 6), STZ-treated C57Bl/6 (n = 6), and ob/ob on C57Bl/6 background (n = 5) mouse hypothalami. Double-stranded cDNA synthesis was reverse-transcribed from 10 µg of isolated RNA from each hypothalamus by using the SuperScript (Invitrogen) with an oligo(dT) primer containing a T7 RNA polymerase promoter site. Double-stranded cDNA was purified with Phase Lock Gel (Eppendorf). Biotin-labeled cRNA was transcribed by using a BioArray RNA transcript
